Lupin makes at-risk launch of metformin ER in the US
This article was originally published in Scrip
Executive Summary
Lupin has launched metformin hydrochloride extended-release 500mg and 1,000mg tablets at risk in the US. The products are generic versions of Watson's diabetes medication Fortamet, which is marketed by Sciele Pharma (now part of Shionogi) in the US.